1,079 results on '"Van den Berg, Maarten P."'
Search Results
52. Relevance of Titin Missense and Non-Frameshifting Insertions/Deletions Variants in Dilated Cardiomyopathy
53. Variant Location Is a Novel Risk Factor for Individuals With Arrhythmogenic Cardiomyopathy Due to a Desmoplakin ( DSP ) Truncating Variant
54. Increased aortic tortuosity indicates a more severe aortic phenotype in adults with Marfan syndrome
55. The Risk for Type B Aortic Dissection in Marfan Syndrome
56. Early action on Paris Agreement allows for more time to change energy systems
57. KBTBD13 is a novel cardiomyopathy gene
58. Programmed Ventricular Stimulation as an Additional Primary Prevention Risk Stratification Tool in Arrhythmogenic Right Ventricular Cardiomyopathy: A Multinational Study
59. Longitudinal Prediction of Ventricular Arrhythmic Risk in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy
60. A cross‐sectional study on fatigue, anxiety, and symptoms of depression and their relation with medical status in adult patients with Marfan syndrome. Psychological consequences in Marfan syndrome
61. Towards a Better Understanding of Genotype–Phenotype Correlations and Therapeutic Targets for Cardiocutaneous Genes: The Importance of Functional Studies above Prediction
62. Periprocedural Complications and Long-Term Outcome After Alcohol Septal Ablation Versus Surgical Myectomy in Hypertrophic Obstructive Cardiomyopathy: A Single-Center Experience
63. Mutations in CYB561 Causing a Novel Orthostatic Hypotension Syndrome
64. How climate metrics affect global mitigation strategies and costs: a multi-model study
65. Plasma levels of danger-associated molecular patterns are associated with immune suppression in trauma patients
66. How well do integrated assessment models represent non-CO2 radiative forcing?
67. Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy According to Revised 2010 Task Force Criteria With Inclusion of Non-Desmosomal Phospholamban Mutation Carriers
68. Circulating transforming growth factor-β as a prognostic biomarker in Marfan syndrome
69. Lamin A/C mutation is independently associated with an increased risk of arterial and venous thromboembolic complications
70. TAB2 deletions and loss-of-function variants cause a Noonan-like syndrome with mitral valve disease, cardiomyopathy and hypermobility
71. A new prediction model for ventricular arrhythmias in arrhythmogenic right ventricular cardiomyopathy
72. Programmed Ventricular Stimulation as an Additional Primary Prevention Risk Stratification Tool in Arrhythmogenic Right Ventricular Cardiomyopathy : A Multinational Study
73. Comparing clinical performance of current implantable cardioverter-defibrillator implantation recommendations in arrhythmogenic right ventricular cardiomyopathy
74. A new prediction model for ventricular arrhythmias in arrhythmogenic right ventricular cardiomyopathy
75. Longitudinal Prediction of Ventricular Arrhythmic Risk in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy
76. KBTBD13 is a novel cardiomyopathy gene
77. Programmed Ventricular Stimulation as an Additional Primary Prevention Risk Stratification Tool in Arrhythmogenic Right Ventricular Cardiomyopathy: A Multinational Study
78. Towards a Better Understanding of Genotype-Phenotype Correlations and Therapeutic Targets for Cardiocutaneous Genes: The Importance of Functional Studies above Prediction
79. Clinical Characteristics and Follow-Up of Pediatric-Onset Arrhythmogenic Right Ventricular Cardiomyopathy
80. Optimal echocardiographic assessment of myocardial dysfunction for arrhythmic risk stratification in phospholamban mutation carriers
81. Comparing clinical performance of current implantable cardioverter-defibrillator implantation recommendations in arrhythmogenic right ventricular cardiomyopathy
82. Sex-specific aspects of phospholamban cardiomyopathy: The importance and prognostic value of low-voltage electrocardiograms
83. Abstract 20814: High Rate of Atrial Arrhythmias in Individuals With Truncating Titin Mutations Including the First Dilated Cardiomyopathy Related Titin Founder Mutation
84. Abstract 18198: A Stepwise Approach Including Whole Exome Sequencing Targeting a Gene Panel for Paediatric Dilated Cardiomyopathy, Potentially Yields a Diagnosis in 50% of Patients
85. Multilevel analyses of SCN5A mutations in arrhythmogenic right ventricular dysplasia/cardiomyopathy suggest non-canonical mechanisms for disease pathogenesis
86. Basal infarct location but not larger infarct size is associated with a successful outcome after alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy: a cardiovascular magnetic resonance imaging study
87. A new prediction model for ventricular arrhythmias in arrhythmogenic right ventricular cardiomyopathy
88. Functional investigation of two simultaneous or separately segregating DSP variants within a single family supports the theory of a dose‐dependent disease severity
89. An International Multi-Center Cohort Study on ß-blockers for the Treatment of Symptomatic Children with Catecholaminergic Polymorphic Ventricular Tachycardia
90. Surgical Treatment of Heart Failure
91. Myocardial Ischemia in Heart Failure: Value of Positron Emission Tomography
92. Systolic and diastolic dysfunction in long-term adult survivors of childhood cancer
93. The Effect of Rate Control on Quality of Life in Patients With Permanent Atrial Fibrillation: Data From the RACE II (Rate Control Efficacy in Permanent Atrial Fibrillation II) Study
94. Effect of Lenient Versus Strict Rate Control on Cardiac Remodeling in Patients With Atrial Fibrillation: Data of the RACE II (RAte Control Efficacy in permanent atrial fibrillation II) Study
95. An International Multicenter Cohort Study on β-Blockers for the Treatment of Symptomatic Children With Catecholaminergic Polymorphic Ventricular Tachycardia
96. The impact of technology availability on the timing and costs of emission reductions for achieving long-term climate targets
97. Hypertrophic remodelling in cardiac regulatory myosin light chain (MYL2) founder mutation carriers
98. Pregnancy course and outcomes in women with arrhythmogenic right ventricular cardiomyopathy
99. Drugs after Cardioversion to Prevent Relapses of Chronic Atrial Fibrillation or Flutter
100. Desmin mutations as a cause of right ventricular heart failure affect the intercalated disks
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.